Norwich Research Park Featured PhD Programmes
Queen’s University Belfast Featured PhD Programmes
Norwich Research Park Featured PhD Programmes

cell therapy PhD Projects, Programs & Scholarships

We have 121 cell therapy PhD Projects, Programs & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


We have 121 cell therapy PhD Projects, Programs & Scholarships

PhD saved successfully

Gene correlation network showing differences in gene expression of effector T cells derived from the bone marrow or peripheral tissues affected by GVHD.

Our group is interested in developing novel immunotherapeutic approaches for leukaemia. Clinical approaches currently used include allogeneic haematopoietic stem cell transplantation, chimeric antigen receptor T cell therapy and immune checkpoint inhibitors. Read more

Gene correlation network showing differences in gene expression of effector T cells derived from the bone marrow or peripheral tissues affected by GVHD.

Our group is interested in developing novel immunotherapeutic approaches for leukaemia. Clinical approaches currently used include allogeneic haematopoietic stem cell transplantation, chimeric antigen receptor T cell therapy and immune checkpoint inhibitors. Read more

In vivo Haematopoietic Stem Cell Gene Therapy for People with Friedreich's Ataxia

Friedreich's ataxia is an incurable neurological disorder, typically presenting in late childhood. Children born with the condition experience progressive accumulation of nervous system damage and neurological disability. Read more

CRG INTERNATIONAL PHD FELLOWSHIPS PROGRAMME

Apply now to boost your scientific career at CRG, a center of excellence, backed by first class core facilities and a broad training portfolio in our multidisciplinary, international community. Read more

Single-Cell CRISPR Analysis of Stromal Support in CRC Patient Derived Organoids

Colorectal cancer (CRC) is the 4th most common cancer in the UK and kills >53,000 people per year worldwide. CRC is characterised by a high inter-patient variability and high intra-tumour genetic heterogeneity. Read more

Macrophage driven therapy resistance in AML: from macrophage subset characterisation to therapeutic targeting.

  Research Group: Molecular Mechanisms and Long Term Conditions
Reference. SHLS20065. Background. Acute Myeloid Leukaemia (AML) is a common blood cancer in adults; with its incidence increasing with age, AML cases are predicted to double by 2030. Read more

Analysing the differentiation and function of the neurons damaged in Huntington's Disease

Summary. Striatal medium spiny neurons (MSNs) bear the brunt of pathology in Huntington’s disease (HD). You will use a range of in vitro and in vivo cell, molecular genetic and whole animal techniques to dissect how the transcription factors FoxP1 and Mef2C function in MSNs differentiation. Read more

Investigation of antagonism of multiple RGD-binding integrins as a therapeutic strategy in advanced head and neck cancer

  Research Group: Institute of Cancer Therapeutics
Background. The integrins are a family of transmembrane receptors which mediate cell-cell and cell-ECM adhesion, and signalling across the cell membrane involved in pathways controlling cell migration, proliferation, differentiation, cell survival and apoptosis. Read more

Unravelling mechanisms of disease progression in Myeloproliferative Neoplasms

The Haematopoietic Stem Cell Biology (HSCB) Laboratory is focused on understanding how the normal haematopoietic stem/progenitor hierarchy is disrupted during the development of myeloid malignancies. Read more

Unravelling mechanisms of disease progression in Myeloproliferative Neoplasms

The Haematopoietic Stem Cell Biology (HSCB) Laboratory is focused on understanding how the normal haematopoietic stem/progenitor hierarchy is disrupted during the development of myeloid malignancies. Read more

Understanding myeloma cell - microenvironment interactions and their role in immunomodulatory drug resistance

Project Description . The bone marrow cancer multiple myeloma remains incurable despite advances in therapy. Immunomodulatory drugs (IMiDs) are the current backbone of standard and experimental combination therapies at all stages of disease. Read more

Single-cell transcriptomics linked to lineage tracing to interrogate the role of 'plasticity first' as a positive force driving paediatric cancer evolution

Project Description . The main goal of this project is to build a comprehensive temporal evolutionary picture, at single cell resolution, to define how paediatric solid cancer evolves during the formation of tumours and in response to both chemo- and targeted therapy. Read more

Filtering Results